Twist Bioscience (NASDAQ: TWST) net income
Twist Bioscience reported a net loss of $77.7m for fiscal 2025; in fiscal 2024 it reported a net loss of $208.7m. Earnings per share were −$1.30.
Twist Bioscience's best year of the last 8 was fiscal 2018. It reported a loss in 8 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$77.7m | — | −20.6% | −$1.30 |
| 2024 | −$208.7m | — | −66.7% | −$3.60 |
| 2023 | −$204.6m | — | −83.5% | −$3.60 |
| 2022 | −$217.9m | — | −107.0% | −$4.04 |
| 2021 | −$152.1m | — | −114.9% | −$3.15 |
| 2020 | −$139.9m | — | −155.3% | −$3.57 |
| 2019 | −$107.7m | — | −198.0% | — |
| 2018 | −$71.2m | — | −280.2% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Twist Bioscience net income compared with its sector
By net income for its latest fiscal year, Twist Bioscience ranks 307th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Twist Bioscience, −20.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 305th | Butterfly Network | −$77.1m | −79.0% |
| 306th | Rezolute | −$77.6m | — |
| 307th | Twist Bioscience | −$77.7m | −20.6% |
| 308th | Surgery Partners | −$77.9m | −2.4% |
| 309th | Avalo Therapeutics | −$78.3m | −132,642.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Twist Bioscience
- How much did Twist Bioscience earn in fiscal 2025?
- Twist Bioscience reported a net loss of $77.7m for fiscal 2025. In fiscal 2024 it reported a net loss of $208.7m.
- What are the earnings per share of Twist Bioscience?
- They were −$1.30 in fiscal 2025, compared with −$3.60 in fiscal 2024.
- Where does Twist Bioscience rank in its sector by net income?
- It ranks 307th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Twist Bioscience come from?
- From the annual report (Form 10-K) that Twist Bioscience files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Twist Bioscience files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Twist Bioscience: the Twist Bioscience page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.